{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:11:07Z","timestamp":1775293867481,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,17]]},"DOI":"10.7759\/cureus.58487","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T21:55:26Z","timestamp":1713390926000},"source":"Crossref","is-referenced-by-count":2,"title":["Vancomycin Flushing Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Shitij","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashwat","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A002","article-title":"Desensitization protocols for vancomycin hypersensitivity","volume":"35","author":"Wazny LD","year":"2001","unstructured":"Wazny LD, Daghigh B. Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother. 2001, 35:1458-64. 10.1345\/aph.1A002","journal-title":"Ann Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199909000-00006","article-title":"Antihistamine prophylaxis permits rapid vancomycin infusion","volume":"27","author":"Renz CL","year":"1999","unstructured":"Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J. Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med. 1999, 27:1732-7. 10.1097\/00003246-199909000-00006","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.4.550","article-title":"Vancomycin-induced histamine release and \"red man syndrome\": comparison of 1- and 2-hour infusions","volume":"34","author":"Healy DP","year":"1990","unstructured":"Healy DP, Sahai JV, Fuller SH, Polk RE. Vancomycin-induced histamine release and \"red man syndrome\": comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother. 1990, 34:550-4. 10.1128\/AAC.34.4.550","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam S","year":"2003","unstructured":"Sivagnanam S, Deleu D. Red man syndrome. Crit Care. 2003, 7:119-20. 10.1186\/cc1871","journal-title":"Crit Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jac.a020861","article-title":"Risk factors for adverse cutaneous reactions associated with intravenous vancomycin","volume":"39","author":"Korman TM","year":"1997","unstructured":"Korman TM, Turnidge JD, Grayson ML. Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother. 1997, 39:371-81. 10.1093\/oxfordjournals.jac.a020861","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4065\/74.9.928","article-title":"Symposium on antimicrobial agents--part XII. Vancomycin","volume":"74","author":"Wilhelm MP","year":"1999","unstructured":"Wilhelm MP, Estes L. Symposium on antimicrobial agents--part XII. Vancomycin. Mayo Clin Proc. 1999, 74:928-35. 10.4065\/74.9.928","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90039-6","article-title":"Vancomycin hypersensitivity: synergism with narcotics and \"desensitization\" by a rapid continuous intravenous protocol","volume":"94","author":"Wong JT","year":"1994","unstructured":"Wong JT, Ripple RE, MacLean JA, Marks DR, Bloch KJ. Vancomycin hypersensitivity: synergism with narcotics and \"desensitization\" by a rapid continuous intravenous protocol. J Allergy Clin Immunol. 1994, 94:189-94. 10.1016\/0091-6749(94)90039-6","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800505","article-title":"Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function","volume":"28","author":"Bergeron L","year":"1994","unstructured":"Bergeron L, Boucher FD. Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function. Ann Pharmacother. 1994, 28:581-4. 10.1177\/106002809402800505","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.01.044","article-title":"Red man syndrome caused by vancomycin powder","volume":"50","author":"Nagahama Y","year":"2018","unstructured":"Nagahama Y, VanBeek MJ, Greenlee JD. Red man syndrome caused by vancomycin powder. J Clin Neurosci. 2018, 50:149-50. 10.1016\/j.jocn.2018.01.044","journal-title":"J Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501243120416","article-title":"Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic","volume":"312","author":"Boag F","year":"1985","unstructured":"Boag F, Chappell M, Beckett AG, Dandona P. Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic. N Engl J Med. 1985, 312:245-6. 10.1056\/NEJM198501243120416","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02032805","article-title":"Vancomycin: renewed interest in an old drug","volume":"3","author":"Farber BB","year":"1984","unstructured":"Farber BB. Vancomycin: renewed interest in an old drug. Eur J Clin Microbiol. 1984, 3:1-3. 10.1007\/BF02032805","journal-title":"Eur J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91687-8","article-title":"Methicillin resistance in Staphylococci","volume":"27","author":"Jevons MP","year":"1963","unstructured":"Jevons MP, Coe AW, Parker MT. Methicillin resistance in Staphylococci. Lancet. 1963, 27:904-7. 10.1016\/S0140-6736(63)91687-8","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak MJ","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al.. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020, 77:835-64. 10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2031891","article-title":"Vancomycin infusion reaction - moving beyond \u201cred man syndrome\u201d","volume":"384","author":"Alvarez-Arango S","year":"2021","unstructured":"Alvarez-Arango S, Ogunwole SM, Sequist TD, Burk CM, Blumenthal KG. Vancomycin infusion reaction - moving beyond \u201cred man syndrome\u201d. N Engl J Med. 2021, 384:1283-6. 10.1056\/NEJMp2031891","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211021417","article-title":"Call to pharmacists: end use of \u201cred man syndrome\u201d","volume":"56","author":"Rivera CG","year":"2022","unstructured":"Rivera CG, Ryan KL. Call to pharmacists: end use of \u201cred man syndrome\u201d. Ann Pharmacother. 2022, 56:102-3. 10.1177\/10600280211021417","journal-title":"Ann Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2021-006233","article-title":"Beyond \u201cred man syndrome\u201d: a case for American Indian health equity","volume":"11","author":"Burns J","year":"2021","unstructured":"Burns J, Empey A. Beyond \u201cred man syndrome\u201d: a case for American Indian health equity. Hosp Pediatr. 2021, 11:e343-5. 10.1542\/hpeds.2021-006233","journal-title":"Hosp Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.027","article-title":"Vancomycin hypersensitivity reactions documented in electronic health records","volume":"9","author":"Alvarez-Arango S","year":"2021","unstructured":"Alvarez-Arango S, Yerneni S, Tang O, et al.. Vancomycin hypersensitivity reactions documented in electronic health records. J Allergy Clin Immunol Pract. 2021, 9:906-12. 10.1016\/j.jaip.2020.09.027","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243942-vancomycin-flushing-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T21:55:29Z","timestamp":1713390929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243942-vancomycin-flushing-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.58487","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}